Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.
Serious Event path is as follows:
Study -> Results Section -> Adverse Events Module -> Serious Event
Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats
| Group ID | # Events | # Affected | # At Risk | View |
|---|---|---|---|---|
| EG005 | None | 0 | 52 | View |
| EG013 | None | 1 | 52 | View |
| EG017 | None | 0 | 18 | View |
| EG021 | None | 0 | 90 | View |
| EG000 | None | 0 | 30 | View |
| EG001 | None | 0 | 20 | View |
| EG002 | None | 0 | 51 | View |
| EG003 | None | 0 | 54 | View |
| EG004 | None | 0 | 50 | View |
| EG006 | None | 0 | 49 | View |
| EG007 | None | 0 | 53 | View |
| EG008 | None | 0 | 51 | View |
| EG009 | None | 0 | 30 | View |
| EG010 | None | 0 | 20 | View |
| EG011 | None | 0 | 51 | View |
| EG012 | None | 0 | 50 | View |
| EG014 | None | 0 | 49 | View |
| EG015 | None | 0 | 53 | View |
| EG016 | None | 0 | 51 | View |
| EG018 | None | 0 | 17 | View |
| EG019 | None | 0 | 19 | View |
| EG020 | None | 0 | 19 | View |
| EG022 | None | 0 | 89 | View |
| EG023 | None | 0 | 12 | View |
| EG024 | None | 0 | 15 | View |
| EG025 | None | 0 | 72 | View |
| EG026 | None | 0 | 68 | View |
| EG027 | None | 0 | 51 | View |
| EG028 | None | 0 | 3 | View |
| EG029 | None | 0 | 11 | View |
| EG030 | None | 0 | 12 | View |
| EG031 | None | 0 | 56 | View |
| EG032 | None | 0 | 8 | View |